State Street Global Advisors Announces Impact of Receiving Payment
14 June 2019 - 7:50AM
Business Wire
The SPDR® Exchange Traded Fund (ETF) listed in the table below,
announced today that the Fund received a payment as an authorized
claimant from a class action settlement related to Salix
Pharmaceuticals, Ltd * (NYSE: BHC) securities litigation.
The total payment to be received by the Fund is listed below.
When the Fund calculates its net asset value (“NAV”) per share on
Friday, June 14, 2019, it is estimated that the Fund’s NAV will be
impacted by the amount stated below based on shares outstanding as
of June 12, 2019.
Fund
PaymentAmount
Shares Outstanding as of June
12, 2019
Per Share Impact
SPDR S&PPharmaceuticalsETF (XPH)
$31,448 5,600,270
$0.0056
* Salix Pharmaceuticals (“Salix”) is a wholly-owned subsidiary
of Bausch Health Companies Inc. (NYSE: BHC)
About SPDR Exchange Traded Funds
SPDR ETFs are a comprehensive family spanning an array of
international and domestic asset classes. SPDR ETFs are managed by
SSGA Funds Management, Inc., a registered investment adviser and
wholly owned subsidiary of State Street Corporation. The funds
provide investors with the flexibility to select investments that
are precisely aligned to their investment strategy. Recognized as
an industry pioneer, State Street created the first US listed ETF
in 1993 (SPDR S&P 500® – Ticker SPY) and has remained on the
forefront of responsible innovation, as evidenced by the
introduction of many ground-breaking products, including
first-to-market launches with gold, international real estate,
international fixed income, and sector ETFs. For more information,
visit www.spdrs.com.
About State Street Global Advisors
For nearly four decades, State Street Global Advisors has been
committed to helping financial professionals and those who rely on
them achieve their investment objectives. We partner with
institutions and financial professionals to help them reach their
goals through a rigorous, research-driven process spanning both
active and index disciplines. We take pride in working closely with
our clients to develop precise investment strategies, including our
pioneering family of SPDR® ETFs. With trillions* in assets under
management, our scale and global footprint provide access to
markets and asset classes, and allow us to deliver expert insights
and investment solutions.
State Street Global Advisors is the investment management arm of
State Street Corporation.
*Assets under management were $2.80 trillion as of March 31,
2019. This figure includes approximately $33 billion of assets with
respect to SPDR products for which State Street Global Advisors
Funds Distributors, LLC (SSGA FD) acts solely as the marketing
agent. SSGA FD and State Street Global Advisors are affiliated.
Important Risk Information:
All ETFs are subject to risk, including possible loss of
principal.
ETFs trade like stocks, are subject to investment risk,
fluctuate in market value and may trade at prices above or below
the ETFs net asset value. Although ETFs may be bought and sold on
the exchange through any brokerage account, ETFs are not
individually redeemable from the Fund. Investors may acquire ETFs
and tender them for redemption through the Fund in Creation Unit
Aggregations only.
Information about XPH is intended for U.S. investors and for
certain non-U.S. investors who are qualified to receive product
information in accordance with a local jurisdiction’s private
placement or marketing restrictions.
The S&P Pharmaceuticals Select Industry Index (the "Index")
represents the pharmaceuticals segment of the S&P Total Market
Index ("S&P TMI"). The S&P TMI is designed to track the
broad U.S. equity market. The pharmaceuticals segment of the
S&P TMI comprises the Pharmaceuticals sub-industry. The Index
is one of twenty-one (21) of the S&P Select Industry Indices
(the "Select Industry Indices"), each designed to measure the
performance of a narrow sub-industry or group of sub-industries
determined based on the Global Industry Classification Standard
("GICS").
Before investing, consider the funds’ investment objectives,
risks, charges and expenses. To obtain a prospectus or summary
prospectus which contains this and other information, call
1-866-787-2257 or visit www.spdrs.com. Read it
carefully.
Not FDIC Insured • No Bank Guarantee • May Lose Value
Intellectual Property Information: Standard &
Poor's®, S&P® and SPDR® are registered trademarks of Standard
& Poor’s Financial Services LLC (S&P); Dow Jones is a
registered trademark of Dow Jones Trademark Holdings LLC (Dow
Jones); and these trademarks have been licensed for use by S&P
Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes
by State Street Corporation. State Street Corporation’s financial
products are not sponsored, endorsed, sold or promoted by SPDJI,
Dow Jones, S&P, their respective affiliates and third party
licensors and none of such parties make any representation
regarding the advisability of investing in such product(s) nor do
they have any liability in relation thereto, including for any
errors, omissions, or interruptions of any index.
State Street Global Advisors, One Iron Street, Boston, MA
02110
© 2019 State Street Corporation - All Rights Reserved
Expiration Date: 6/30/2020
2585341.1.1.AM.RTL
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190613005793/en/
Olivia Offner+1 617-662-0198ooffner@statestreet.com
State Street (NYSE:STT)
Historical Stock Chart
From Apr 2024 to May 2024
State Street (NYSE:STT)
Historical Stock Chart
From May 2023 to May 2024